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S U M M A R Y
Background: Pneumonia is the leading cause of hospital admission during the annual Islamic pilgrimage
(Hajj). The etiology of severe pneumonia is complex and includes the newly emerged Middle East
respiratory syndrome coronavirus (MERS-CoV). Since 2012, the Saudi Ministry of Health (MoH) has
required screening for MERS-CoV for all cases of severe pneumonia requiring hospitalization. We aimed
to screen Hajj pilgrims admitted to healthcare facilities in 2013 with severe community-acquired
pneumonia (CAP) for MERS-CoV and to determine other etiologies.
Methods: Sputum samples were collected from all pilgrims admitted to 15 healthcare facilities in the
cities of Makkah and Medina, Saudi Arabia, who were diagnosed with severe CAP on admission,
presenting with bilateral pneumonia. The medical records were reviewed to collect information on age,
gender, nationality, and patient outcome. Samples were screened for MERS-CoV by PCR, and a
respiratory multiplex array was used to detect up to 22 other viral and bacterial respiratory pathogens.
Results: Thirty-eight patients met the inclusion criteria; they were predominantly elderly (mean age
58.6 years, range 25–83 years) and male (68.4%), and all were from developing countries. Fourteen of the
38 patients died (36.8%). MERS-CoV was not detected in any of the samples. Other respiratory pathogens
were detected in 26 (68.4%) samples. Of these, bacterial pathogens were detected in 84.6% (22/26) and
viruses in 80.7% (21/26). Twenty-one (80.7%) samples were positive for more than one respiratory
pathogen and 17 (65.3%) were positive for both bacteria and viruses. The most common respiratory virus
was human rhinovirus, detected in 57.7% of the positive samples, followed by inﬂuenza A virus (23.1%)
and human coronaviruses (19.2%). Haemophilus inﬂuenzae and Streptococcus pneumoniae were the
predominant bacteria, detected in 57.7% and 53.8%, respectively, of the positive samples, followed by
Moraxella catarrhalis (36.4%).
Conclusions: MERS-CoV was not the cause of severe CAP in any of the hospitalized pilgrims investigated.
However we identiﬁed a variety of other respiratory pathogens in the sputum of this small number of
patients. This indicates that the etiology of severe CAP in Hajj is complex with implications regarding its
management.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Pneumonia is the leading cause of hospital admission during
the annual Islamic pilgrimage (Hajj), including admission to
intensive care units (ICUs), and is a major cause of severe sepsis* Corresponding author. Tel.: +966 11 2124052; fax: +966 11 2125052.
E-mail address: zmemish@yahoo.com (Z.A. Memish).
http://dx.doi.org/10.1016/j.ijid.2014.06.003
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).and septic shock in ICUs during this mass-gathering.1–4 Studies
from seven hospitals in the Hajj premises (Mina and Arafat)
reported that pneumonia accounted for 19.7% of all hospital
admissions during the 2003 Hajj and 22% of ICU admissions during
the 2004 season.1,2 The incidence of pneumonia during Hajj is also
increasing. The reported incidence among Iranian pilgrims at Hajj
was 24 per 10 000 in 2004 and 34 per 10 000 in 2005, which
represents a greater than 50-fold increase compared with the 1986
data.5,6ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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during Hajj. Mandourah and colleagues investigated all critically ill
patients, who were of over 40 nationalities, admitted to 15 hospitals
in two cities in the 2009 and 2010 Hajj seasons.3 Pneumonia was the
primary cause of critical illness in 27.2% (123 cases) of all ICU
admissions and occurred most commonly in the second week of
Hajj, corresponding to the period of greatest pilgrim density. Severe
CAP accounted for 18.1% of all ICU admissions.
Worldwide, pneumonia is a common illness that is potentially
life-threatening, especially in older adults and those with
comorbid diseases.7,8 The etiology of pneumonia differs between
and within countries depending on regional differences in
prevalence and types of microorganism, and other factors such
as the frequency of use of antibiotics, environmental pollution,
awareness of the disease, and life-expectancy of the population.9
The etiology may also differ depending on whether the pneumonia
is community- or hospital-acquired.7,8 In this context, the Hajj is a
special case as it brings a large number of people, many elderly
with underlying diseases, from various regions of the world, into
close proximity to perform physically exhausting religious rights.
These factors, combined with the common use of antibiotics
among pilgrims, make the etiology of pneumonia during Hajj
complex, and hence standard guidelines for the management of the
disease may not always work during this mass-gathering event.
Although many pathogens have been associated with pneumo-
nia, a small range of key pathogens are usually the cause of most
cases.7,10 In recent years, the Middle East respiratory syndrome
coronavirus (MERS-CoV) has also emerged as a cause of serious
illness including severe pneumonia.11 Since the ﬁrst reported case
of MERS in Saudi Arabia in 2012,12 the Saudi Ministry of Health
(MoH) has set up an ongoing MERS-CoV surveillance system. As
part of this surveillance, it is required that all cases of severe CAP
with bilateral pneumonia requiring hospitalization are investigat-
ed for MERS-CoV.
Hence, we used molecular techniques to screen the sputum of
Hajj pilgrims diagnosed with severe CAP requiring hospitalization
in 2013 for the presence of MERS-CoV. Other etiologies were also
investigated using a respiratory multiplex array to detect bacterial
and viral respiratory pathogens.
2. Methods
2.1. Patient population
All pilgrims attending the 2013 Hajj who were admitted to 15
healthcare facilities in the cities of Makkah and Medina, Saudi
Arabia, and diagnosed on admission with bilateral pneumonia,
were included in the study. The medical records of the patients
were reviewed to collect information on age, gender, nationality,
and patient outcome.
2.2. Sputum sample collection and storage
During the period 26 September to 2 November 2013, sputum
samples were collected from each patient on admission, prior to
any antibiotic therapy. Samples were kept refrigerated until
processing.
2.3. Nucleic acid extraction and detection of MERS-CoV in sputum
samples
MERS-CoV was detected in the samples using reverse tran-
scriptase polymerase chain reactions (RT-PCR) targeting the region
upstream of the E gene (upE) and the open reading frame (ORF) 1a
(nsp6 protein), as described previously.13,14 Brieﬂy, nucleic acid
was puriﬁed from a 200-ml volume of sample using the MagnaPure LC Nucleic Acid Extraction Kit (Roche, IN, USA). Each sample
was independently tested with the two RT-PCR assays in a 25-ml
reaction containing 5 ml of RNA, 12.5 ml of 2X buffer (SuperScript
III one-Step RT-PCR with Platinum Taq (Invitrogen, NY, USA)),
0.4 ml of MgCl2 (50 mM), 1 ml of forward primer (10 mM), 1 ml of
reverse primer (10 mM), 1 ml of probe (5 mM), 3.1 ml RNAse free
H2O2, and 1 ml of SSIII/Platinum Taq enzyme mix (1 U). The RT-PCR
reactions were performed in a Real Time LC 480 machine (Roche,
IN, USA) under the following cycling proﬁle: one cycle of 55 8C for
20 min, followed by one cycle of 94 8C for 3 min then 45 cycles of
94 8C for 15 s, 45 cycles of 58 8C for 30 s, and a single cycle of 40 8C
for 30 s. A sample was conﬁrmed MERS-CoV-positive if both RT-
PCR assays were positive, as per current recommendations.14
2.4. Nucleic acid extraction and detection of other respiratory
pathogens in sputum samples
Nucleic acid was extracted from the samples using the MinElute
Virus Spin Kit (Qiagen, Manchester, UK) following the manufac-
turer’s instructions and eluted in 50 ml nuclease-free water. A 5-ml
aliquot of each of the nucleic acid extractions was run on the
respiratory multiplex array (Randox, Crumlin, UK), which is
capable of detecting 22 bacterial and viral respiratory pathogens
simultaneously. These are inﬂuenza virus A and B, human
respiratory syncytial virus A and B, human parainﬂuenza virus
1, 2, 3 and 4, human coronavirus 229E/NL63 and OC43/HKU1,
human rhinovirus A/B, human enterovirus A/B/C, human adenovi-
rus A/B/C/D/E, human bocavirus 1/2/3, human metapneumovirus,
Chlamydophila pneumoniae, Legionella pneumophila, Haemophilus
inﬂuenzae, Bordetella pertussis, Streptococcus pneumoniae, Moraxella
catarrhalis, and Mycoplasma pneumoniae.
3. Results
We collected sputum samples from all pilgrims hospitalized in 15
hospitals of two cities in Saudi Arabia who were diagnosed with
severeCAPduringthe2013Hajjseason.Thirty-eightpatientsfulﬁlled
the inclusion criteria; they were predominantly elderly (mean age
58.6 years, range 25–83 years) and male (68.4%). All patients were
from developing countries, the majority of whom (78.3%) were from
Asia. The nationalities most represented were Indonesia (32.4%),
Pakistan (18.9%), and India (10.8%). Of the 38 patients, 30 (78.9%)
required ICU admission. Fourteen (36.8%) patients died, while the
remaining patients recovered and were discharged. The mortality
rate among those admitted to the ICUs was 46.6%.
MERS-CoV was not detected in any of the sputum samples.
Other respiratory pathogens were detected in 26 (68.4%) of the 38
samples, while the remaining samples were negative for the 22
respiratory pathogens in the testing panel (Table 1). Of the positive
samples, bacterial pathogens were detected in 84.6% (22/26) and
viruses in 80.7% (21/26). Twenty-one (80.7%) samples were
positive for more than one respiratory pathogen and 17 (65.3%)
were positive for both bacteria and viruses.
The most common respiratory virus was human rhinovirus,
which was detected in 57.7% of the positive amples, followed by
inﬂuenza A virus (23.1%) and human coronaviruses (19.2%). H.
inﬂuenzae and S. pneumoniae were the predominant bacteria,
detected in 57.7% and 53.8%, respectively, of the positive samples,
followed by M. catarrhalis (36.4%).
4. Discussion
Respiratory tract infections are common illnesses during the
Hajj,15 and pneumonia is the leading cause of hospital admission,
including admission to the ICU, during the pilgrimage.1–4,16 For
instance, a study of hospital admissions in Makkah and Mina
Table 1
Characteristics of patients with bilateral pneumonia during the 2013 Hajj and respiratory pathogens detected in their sputum
Patient Age, years Gender Patient
outcome
MERS-CoV
in sputum
Respiratory pathogens detected in sputum
Viruses Bacteria
1 51 Male Died Negative HRV
2 67 Female Died Negative HRV SP
3 70 Male Died Negative PIV3, OC43 HI, MC, SP
4 58 Male Died Negative HRV
5 75 Female Recovered Negative HRV, 229E HI, MC, SP
6 75 Male Died Negative HRV, 229E, RSV-B HI, SP, BP
7 67 Male Died Negative HI, SP
8 55 Male Recovered Negative HRV HI, MC
9 66 Female Recovered Negative HRV MC
10 72 Female Recovered Negative HRV HI, MC
11 67 Male Recovered Negative FLU-A MC
12 65 Male Recovered Negative HRV HI, MC, SP
13 59 Male Died Negative FLU-A, 229E HI, SP
14 64 Male Recovered Negative HRV SP
15 59 Male Died Negative FLU-A MC, SP
16 55 Female Died Negative FLU-A HI, MC, SP
17 70 Male Died Negative HRV, FLU-A HI
18 60 Male Died Negative HRV, FLU-A HI, MC
19 57 Male Recovered Negative OC43
20 50 Male Recovered Negative SP
21 55 Male Recovered Negative HI, SP
22 61 Male Recovered Negative HRV HI
23 79 Male Recovered Negative HRV
24 72 Male Recovered Negative HI
25 54 Male Recovered Negative HI, SP
26 60 Male Recovered Negative HRV SP
27 83 Female Died Negative Negative Negative
28 50 Male Died Negative Negative Negative
29 70 Male Died Negative Negative Negative
30 42 Male Recovered Negative Negative Negative
31 - Female Recovered Negative Negative Negative
32 25 Female Recovered Negative Negative Negative
33 26 Female Recovered Negative Negative Negative
34 27 Female Recovered Negative Negative Negative
35 58 Male Recovered Negative Negative Negative
36 25 Female Recovered Negative Negative Negative
37 72 Male Recovered Negative Negative Negative
38 50 Female Recovered Negative Negative Negative
MERS-CoV, Middle East respiratory syndrome coronavirus; HRV, human rhinovirus A/B/C; FLU-A, inﬂuenza A virus; PIV3, human parainﬂuenza virus 3; OC43, human
coronavirus OC43/HKU1; 229E, human coronavirus 229E/NL63; RSV-B, human respiratory syncytial virus B; HI, Haemophilus inﬂuenzae; MC, Moraxella catarrhalis; SP,
Streptococcus pneumoniae; BP, Bordetella pertussis.
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pneumonia.16
In the current study, as part of the Saudi MoH MERS-CoV
surveillance, we investigated the etiology of severe CAP in pilgrims
attending the 2013 Hajj requiring hospitalization. Most of the 38
patients were elderly, with a large proportion of males, and all
were from developing countries. These observations are similar to
those of previous reports investigating pneumonia during Hajj.17,18
For example, Alzeer and colleagues investigated 64 patients
admitted with pneumonia to hospitals in the 1994 Hajj season.17
Nearly all patients were from developing countries; their mean age
was 63 years (range 21–91 years) and 75% were males.
The overall mortality rate among the patients we investigated
was 36.8%, and among those admitted to ICUs was 46.6%.
Internationally, the reported mortality of patients with severe
CAP requiring ICU admission is over 30% and the long-term
mortality of CAP is between 35.8% and 39.1% at 5 years.8,19,20 Our
results are in agreement with these ﬁgures. A few investigations
have reported the mortality rates from pneumonia during Hajj.
One study5 during the 1986 Hajj season reported a pneumonia case
fatality rate of 34%, while another17 reported a mortality rate of
17% among 64 patients admitted to hospitals in the 1994 Hajj
season. Mandourah and colleagues investigated severe pneumonia
during the 2009 and 2010 Hajj seasons.3 Pneumonia wascommunity (Hajj)-acquired in 66.7% of cases and the overall
short-term mortality (during the 3 weeks of Hajj) was 19.5%.
Most patients with diagnosed CAP are treated empirically and
the role of microbiological testing for patients with CAP is still a
matter of debate.7 However there is a clear rationale for
establishing the causative agent to allow the optimal selection
of agents against a speciﬁc pathogen and to limit the misuse of
antibiotics and its consequences; it is also important to identify
pathogens associated with notiﬁable diseases such as Legionnaires’
disease and tuberculosis.21 The possible involvement of MERS-CoV
is an additional, current, reason. Knowledge of the etiological agent
of pneumonia-related illness is a challenging step in the
management of pneumonia in Hajj.1–3,17 In general, the identiﬁca-
tion of the etiology of CAP remains difﬁcult in any setting despite
advances in microbiological and serological methods. Molecular
diagnostic tests for common and atypical causative pathogens of
CAP are now available and have increased the diagnostic yield and
decreased the time required to render results dramatically.22–24
Although many pathogens have been associated with CAP, a
small range of key pathogens are the cause of most cases.
Internationally, the predominant pathogen in CAP is S. pneumo-
niae.7,10 Other causative agents include, but are not limited to,
H. inﬂuenzae, M. pneumoniae, C. pneumoniae, Legionella spp,
Chlamydia psittaci, Coxiella burnetii, enteric Gram-negative bacteria
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us, anaerobes, and respiratory viruses (inﬂuenza virus, adenovirus,
respiratory syncytial virus, parainﬂuenza virus, coronavirus).7,8 The
frequencies of other causes, such as Mycobacterium tuberculosis,
C. psittaci, C. burnetii, Francisella tularensis, and endemic fungi
(histoplasmosis, coccidioidomycosis, blastomycosis) vary between
epidemiological settings.7 Recently, MERS-CoV has also emerged as
a cause of serious illnesses including pneumonia and is the subject
of worldwide concern.11
The primary objective of the study was to determine if MERS-
CoV was the cause of the severe pneumonia in the hospitalized
patients. Our results indicate that MERS-CoV was not the
etiological agent of the illness. These results support previous
reports suggesting that MERS-CoV has not so far been problematic
during Hajj. A study conducted during the 2013 Hajj, the same year
as our study, found no evidence of MERS-CoV nasal carriage among
5235 Hajj pilgrims screened. Two reports on French pilgrims
during the 2012 and 2013 Hajj seasons also reported a lack of
MERS-CoV nasal carriage among the pilgrims screened despite a
high rate of respiratory symptoms.25,26
We found S. pneumoniae to be prevalent in the sputum
samples. This is in accordance with many international
reports.7,10 Studies performed during previous Hajj seasons
have reported the organism as a cause of respiratory tract
infections including penumonia.3,17,18 For example, among 395
sputum samples collected from Hajjis with respiratory tract
infections in 1991 and 1992, S. pneumoniae was detected in 4.8%
and 12.3%, respectively.27 Among the 64 patients with pneumo-
nia admitted to two tertiary hospitals in Makkah during the 1994
Hajj, S. pneumoniae was detected in 9.4% of the cases.17 A more
recent study reported that 5.4% of sputum samples collected in
Makkah hospitals during the 2005 Hajj contained S. pneumo-
niae,18 while 10% of sputum samples from patients with severe
pneumonia during the 2009 and 2010 Hajj contained Strepto-
coccus sp.3
In addition to S. pneumoniae, other common pathogens
identiﬁed in our sputum samples were H. inﬂuenzae, M. catarrhalis,
and viral agents, in particular human rhinovirus, inﬂuenza A virus,
and human coronaviruses. Studies from the Gulf Corporation
Council (GCC) states have found similar results. The common
pathogens causing CAP in GCC states were found to be S.
pneumoniae, H. inﬂuenzae, and M. catarrhalis.28,29 In addition, the
importance of atypical pathogens including M. pneumoniae, C.
pneumoniae, and L. pneumophila in the etiology of CAP in the GCC
region has been documented.28 Other etiologies, particularly
inﬂuenza viruses, varicella zoster virus, and M. tuberculosis, are
increasingly recognized as causative pathogens of CAP within the
region.28
In the context of Hajj, in addition to S. pneumoniae, a number of
other organisms have been reported as the cause of pneumonia.
These include inﬂuenza A (H1N1),3 M. tuberculosis,1,3,17,18 S.
aureus,3 fungi such as Candida albicans,3,18 and Gram-negative
organisms including P. aeruginosa, L. pneumophila, Acinetobacter sp,
and members of the Enterobacteriaceae family.3,17,18 Some,
however, have dismissed many of these organisms as more likely
to be respiratory tract colonizers rather than the causative
agents.30
In our study, respiratory pathogens were detected in 68.4% of
sputum samples (26/38) and 80.7% (21/26) of these were positive
for more than one pathogen. This is a higher proportion than that
reported previously by Asghar et al., who isolated more than one
pathogen in only 16.3% of the samples from 76 patients with
conﬁrmed CAP in the 2005 Hajj.18 In another study, a higher
percentage (35%) was reported.24 The differences in detection rates
may reﬂect the differences in identiﬁcation methods used in the
various studies.Our study has some limitations. In addition to MERS-CoV, our
test panel detects a speciﬁc set of 22 bacterial and viral respiratory
pathogens. This means that other respiratory pathogens including
fungi and other viruses and bacteria not included in the panel could
have been missed. This may be of importance, as organisms not
included in the panel such as M. tuberculosis, Enterobacteriaceae, P.
aeruginosa, and fungi, have been reported as causative agents of
pneumonia during Hajj.3,17,18 Also, we only used sputum samples
for identiﬁcation, and no microbiological investigations of other
samples (e.g. blood) were performed to conﬁrm the cause of
pneumonia. Finally, some of the organisms identiﬁed may have
been respiratory tract colonizers and not the causative agents. In
this context, a strength of our study is that the sputum samples
were obtained on admission and before the start of antibiotic
therapy. Collecting sputum samples after the start of antibiotic
treatment would have been of little value as it would have detected
mainly respiratory tract colonizers.
In conclusion, we investigated the etiology of severe CAP in 38
hospitalized Hajj pilgrims. MERS-CoV was not the cause of
pneumonia in any of the patients. However, we detected a variety
of pathogens in sputum samples of the patients, with most samples
containing more than one agent. This observation, along with
previous reports on CAP in Hajj, indicates that typical pneumonia
treatment regimens may not work well during the Hajj season due to
the wide variety of organisms that may be involved. This may
necessitate more active investigations into the causes of pneumonia
for identiﬁcation and sensitivity testing in order to provide optimal
treatment and a good outcome. Molecular methods can be a quick
and sensitive means to determine the possible causative agents.
Pneumonia is a signiﬁcant illness during Hajj and interventions to
reduce its burden during the pilgrimage should be adopted.
Measures to reduce respiratory tract infections during Hajj are
already in place.31 Other strategies may include improved respira-
tory tract infection surveillance and optimization and dissemination
of recommendations for adult vaccination.32,33 Continuous surveil-
lance for MERS-CoV during Hajj and outside the pilgrimage season is
crucial to monitor the MERS-CoV situation in Saudi Arabia.
Conﬂict of interest: No conﬂict of interest to declare.
References
1. Madani TA, Ghabrah TM, Albarrak AM, Alhazmi MA, Alazraqi TA, Althaqaﬁ AO,
et al. Causes of admission to intensive care units in the Hajj period of the Islamic
year 1424 (2004). Ann Saudi Med 2007;27:101–5.
2. Madani TA, Ghabrah TM, Al-Hedaithy MA, Alhazmi MA, Alazraqi TA, Albarrak
AM, et al. Causes of hospitalization of pilgrims in the Hajj season of the Islamic
year 1423 (2003). Ann Saudi Med 2006;26:346–51.
3. Mandourah Y, Al-Radi A, Ocheltree AH, Ocheltree SR, Fowler RA. Clinical and
temporal patterns of severe pneumonia causing critical illness during Hajj. BMC
Infect Dis 2012;12:117.
4. Baharoon S, Al-Jahdali H, Al Hashmi J, Memish ZA, Ahmed QA. Severe sepsis and
septic shock at the Hajj: etiologies and outcomes. Travel Med Infect Dis
2009;7:247–52.
5. Ghaznawi HI, Khalil MH. Health hazards and risk factors in the 1406 H (1986 G)
Hajj season. Saudi Med J 1988;9:274–82.
6. Meysamie A, Ardakani HZ, Razavi SM, Doroodi T. Comparison of mortality and
morbidity rates among Iranian pilgrims in Hajj 2004 and 2005. Saudi Med J
2006;27:1049–53.
7. File TM. Community-acquired pneumonia. Lancet 2003;362:1991–2001.
8. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al. BTS
guidelines for the management of community acquired pneumonia in adults:
update 2009. Thorax 2009;64(Suppl 3):iii1–55.
9. Shah BA, Singh G, Naik MA, Dhobi GN. Bacteriological and clinical proﬁle of commu-
nity acquired pneumonia in hospitalized patients. Lung India 2010;27:54–7.
10. Peto L, Nadjm B, Horby P, Ngan TT, van Doom R, Kinh NV, et al. The bacterial
aetiology of adult community-acquired pneumonia in Asia: a systematic re-
view. Trans R Soc Trop Med Hyg 2014;108:326–37.
11. The WHO MERS-CoV Research Group. State of knowledge and data gaps of
Middle East respiratory syndrome coronavirus (MERS-CoV) in humans. PLoS
Curr 2013;5.
12. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation
of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med
2012;367:1814–20.
Z.A. Memish et al. / International Journal of Infectious Diseases 25 (2014) 186–19019013. Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, et al.
Detection of a novel human coronavirus by real-time reverse-transcription
polymerase chain reaction. Euro Surveill 2012;17. pii: 20288.
14. Corman VM, Muller MA, Costabel U, Timm J, Binger T, Meyer B, et al. Assays for
laboratory conﬁrmation of novel human coronavirus (hCoV-EMC) infections.
Euro Surveill 2012;17. pii: 20334.
15. Alzeer AH. Respiratory tract infection during Hajj. Ann Thorac Med 2009;4:50–3.
16. Al-Ghamdi SM, Akbar HO, Qari YA, Fathaldin OA, Al-Rashed RS. Pattern of
admission to hospitals during Muslim pilgrimage (Hajj). Saudi Med J 2003;24:
1073–6.
17. Alzeer A, Mashlah A, Fakim N, Al-Sugair N, Al-Hedaithy M, Al-Majed S, et al.
Tuberculosis is the commonest cause of pneumonia requiring hospitalization
during Hajj (pilgrimage to Makkah). J Infect 1998;36:303–6.
18. Asghar AH, Ashshi AM, Azhar EI, Bukhari SZ, Zafar TA, Momenah AM. Proﬁle of
bacterial pneumonia during Hajj. Indian J Med Res 2011;133:510–3.
19. Houck PM, MacLehose RF, Niederman MS, Lowery JK. Empiric antibiotic therapy
and mortality among Medicare pneumonia inpatients in 10 western states:
1993, 1995, and 1997. Chest 2001;119:1420–6.
20. Walden AP, Clarke GM, McKechnie S, Hutton P, Gordon AC, Rello J, et al. Patients
with community acquired pneumonia admitted to European Intensive
Care Units: an epidemiological survey of the GenOSept cohort. Crit Care
2014;18:R58.
21. Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ. Practice
guidelines for the management of community-acquired pneumonia in adults.
Infectious Diseases Society of America. Clin Infect Dis 2000;31:347–82.
22. Bartlett JG. Diagnostic tests for agents of community-acquired pneumonia. Clin
Infect Dis 2011;52(Suppl 4):S296–304.
23. Nolte FS. Molecular diagnostics for detection of bacterial and viral patho-
gens in community-acquired pneumonia. Clin Infect Dis 2008;47(Suppl 3):
S123–6.24. Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Etiology of
community-acquired pneumonia: increased microbiological yield with new
diagnostic methods. Clin Infect Dis 2010;50:202–9.
25. Gautret P, Charrel R, Belhouchat K, Drali T, Benkouiten S, Nougairede A, et al.
Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims
returning from the Hajj 2012, despite a high rate of respiratory symptoms. Clin
Microbiol Infect 2013;19:E315–7.
26. Gautret P, Charrel R, Benkouiten S, Belhouchat K, Nougairede A, Drali T, et al.
Lack of MERS coronavirus but prevalence of inﬂuenza virus in French pilgrims
after 2013 Hajj. Emerg Infect Dis 2014;20:728–30.
27. El-Sheikh SM, El-Assouli SM, Mohammed KA, Albar M. Bacteria and viruses that
cause respiratory tract infections during the pilgrimage (Haj) season in Makkah,
Saudi Arabia. Trop Med Int Health 1998;3:205–9.
28. Memish ZA, Ahmed QA, Arabi YM, Shibl AM, Niederman MS. Microbiology of
community-acquired pneumonia in the Gulf Corporation Council states. J
Chemother 2007;19(Suppl 1):17–23.
29. Al-Muhairi S, Zoubeidi T, Ellis M, Nicholls MG, Safa W, Joseph J. Demographics
and microbiological proﬁle of pneumonia in United Arab Emirates. Monaldi Arch
Chest Dis 2006;65:13–8.
30. Karabay O, Yahyaoglu M. Aetiological agents of community acquired pneumo-
nia. Indian J Med Res 2012;136:304–5.
31. Al-Tawﬁq JA, Zumla A, Memish ZA. Respiratory tract infections during the
annual Hajj: potential risks and mitigation strategies. Curr Opin Pulm Med
2013;19:192–7.
32. Feldman C, Abdulkarim E, Alattar F, Al Lawati F, Al Khatib H, Al Maslamani M,
et al. Pneumococcal disease in the Arabian Gulf: recognizing the challenge and
moving toward a solution. J Infect Public Health 2013;6:401–9.
33. Rashid H, Abdul Muttalif AR, Mohamed Dahlan ZB, Djauzi S, Iqbal Z, Karim HM,
et al. The potential for pneumococcal vaccination in Hajj pilgrims: expert
opinion. Travel Med Infect Dis 2013;11:288–94.
